NCT04822363View on ClinicalTrials.gov

The Accuracy of a Novel Platelet Activity Assay in Humans on Antiplatelet Agents: Pharmacodynamics and Comparison with Light Transmission Aggregometry

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

August 20, 2021

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions
Platelet Activation Testing Before/after Anti-platelet TherapyHealthy
Interventions
DRUG

Aspirin

Low dose aspirin in Arms A and D and High Dose Aspirin in Arm B

DRUG

Clopidogrel

Arms C and E

Trial Locations (1)

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Beth Israel Deaconess Medical Center

OTHER